Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio Alvarenga

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Breast Imaging|February 28, 2024
Decreasing the Interval Wait Times for Screening Mammogram Results Using the "Reflex Testing" AlgorithmJulio Alvarenga, Jay Moran, Anca Bulgaru, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
A Comparison of Radiation and Alkylator-Based Conditioning Therapy Regimens for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Clinician's PerspectiveAlejandro Marinos Velarde, Julio Alvarenga Thiebaud, Yazan Madanat, et al.
Translational Cancer Research|February 4, 2022
Older breast cancer undertreatment: unconscious bias to undertreat-potential role for the international geriatric radiotherapy group?Nam P Nguyen, Ulf Karlsson, Eromosele Oboite, et al.
Cancer|August 9, 2022
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcomaJulio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, et al.
Blood Neoplasia|November 24, 2025
Predicting secondary myeloid neoplasms in acquired aplastic anemia using machine learning modelsAhmet Celal Toprak, Mutlu Mete, Julia J Shi, et al.
International Journal of Laboratory Hematology|January 21, 2025
Clinicopathologic and Molecular Characterization of NUP98-Rearranged Acute LeukemiasSujata Sajjan, Estelle E Oertling, Franklin Fuda, et al.
Leukemia & Lymphoma|March 7, 2025
Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohortMarisa L Kometas, Fieke W Hoff, Jonathan Hyak, et al.
Blood|July 25, 2022
The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysisArmin Ghobadi, Michael Slade, Hagop Kantarjian, et al.
Molecular Cancer Therapeutics|December 14, 2016
Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer CellsEmiliano Cocco, Yang Deng, Erik M Shapiro, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Breast Imaging|February 28, 2024
Decreasing the Interval Wait Times for Screening Mammogram Results Using the "Reflex Testing" AlgorithmJulio Alvarenga, Jay Moran, Anca Bulgaru, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
A Comparison of Radiation and Alkylator-Based Conditioning Therapy Regimens for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Clinician's PerspectiveAlejandro Marinos Velarde, Julio Alvarenga Thiebaud, Yazan Madanat, et al.
Translational Cancer Research|February 4, 2022
Older breast cancer undertreatment: unconscious bias to undertreat-potential role for the international geriatric radiotherapy group?Nam P Nguyen, Ulf Karlsson, Eromosele Oboite, et al.
Cancer|August 9, 2022
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcomaJulio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, et al.
Blood Neoplasia|November 24, 2025
Predicting secondary myeloid neoplasms in acquired aplastic anemia using machine learning modelsAhmet Celal Toprak, Mutlu Mete, Julia J Shi, et al.
International Journal of Laboratory Hematology|January 21, 2025
Clinicopathologic and Molecular Characterization of NUP98-Rearranged Acute LeukemiasSujata Sajjan, Estelle E Oertling, Franklin Fuda, et al.
Leukemia & Lymphoma|March 7, 2025
Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohortMarisa L Kometas, Fieke W Hoff, Jonathan Hyak, et al.
Blood|July 25, 2022
The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysisArmin Ghobadi, Michael Slade, Hagop Kantarjian, et al.
Molecular Cancer Therapeutics|December 14, 2016
Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer CellsEmiliano Cocco, Yang Deng, Erik M Shapiro, et al.
Pageof 1